Analyze Diet

The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion–A case series.

Abstract: Five horses were presented for treatment of atrial fibrillation by transvenous electrical cardioversion (TVEC). A dexmedetomidine infusion was administered for sedation during positioning of the cardioversion catheters, and continued during general anesthesia. Shocks were applied until return to sinus rhythm. Dexmedetomidine infusion provided excellent conditions for TVEC catheter placement and procedure. Utilisation d’une perfusion continue de dexmedetomidine lors de cardioversion électrique transveineuse chez le cheval: une série de cas. Cinq chevaux présentant une fibrillation atriale ont été traités par cardioversion éléctrique transveineuse (TVEC). Pour le positionnement des cathéters de cardioversion, les chevaux ont reçu une perfusion de dexmédétomidine, poursuivie pendant l’anesthésie générale. Les chocs éléctriques sont répétés jusqu’au retour en rythme sinusal. La perfusion de dexmédétomidine a fourni d’excellentes conditions pour le positionnement des cathéters et la procédure de TVEC.(Traduit par les auteurs).
Publication Date: 2016-01-08 PubMed ID: 26740702PubMed Central: PMC4677613
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research studies the use of dexmedetomidine in horses undergoing transvenous electrical cardioversion (TVEC). This procedure aimed to treat atrial fibrillation with dexmedetomidine providing sedation for the placement of TVEC catheters and during the general anesthesia.

Study Objective and Methodology

  • The primary objective of this study was to investigate the effectiveness of dexmedetomidine infusion for sedation in horses undergoing transvenous electrical cardioversion (TVEC). TVEC is a procedure used for the treatment of atrial fibrillation, a common cardiac arrhythmia in horses.
  • The research was conducted on five horses that were presented for atrial fibrillation treatment. The horses were sedated with a dexmedetomidine infusion during the positioning of the cardioversion catheters and it was continued throughout the period of general anesthesia.
  • Electrical shocks were repeatedly applied until the sinus rhythm, which is the normal beating of the heart, was achieved.

Findings

  • The researchers noted that the dexmedetomidine infusion provided excellent conditions for the placement of the TVEC catheters and the subsequent procedure.
  • The medication effectively sedated the horses, allowing the procedure to be conducted smoothly and successfully.
  • It suggests that dexmedetomidine is an effective tool in managing horses undergoing TVEC, offering significant benefits in terms of patient management and procedure success.

Conclusion

  • The study concludes that dexmedetomidine infusion could be a viable and effective method of sedation in horses that are undergoing the TVEC procedure.
  • It provided excellent conditions for catheter placement and the overall execution of the procedure and is, therefore, recommended for use in such instances.
  • These findings could have significant implications for the veterinary field, helping to improve patient outcomes and procedure success rates in treating atrial fibrillation in horses.

Cite This Article

APA
Marly-Voquer C, Schwarzwald CC, Bettschart-Wolfensberger R. (2016). The use of dexmedetomidine continuous rate infusion for horses undergoing transvenous electrical cardioversion–A case series. Can Vet J, 57(1), 70-75.

Publication

ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 57
Issue: 1
Pages: 70-75

Researcher Affiliations

Marly-Voquer, Charlotte
  • Equine Department, Anaesthesiology Section (Marly-Voquer, Bettschart-Wolfensberger), Clinic for Equine Internal Medicine (Schwarzwald), Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Schwarzwald, Colin C
  • Equine Department, Anaesthesiology Section (Marly-Voquer, Bettschart-Wolfensberger), Clinic for Equine Internal Medicine (Schwarzwald), Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Bettschart-Wolfensberger, Regula
  • Equine Department, Anaesthesiology Section (Marly-Voquer, Bettschart-Wolfensberger), Clinic for Equine Internal Medicine (Schwarzwald), Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

MeSH Terms

  • Animals
  • Atrial Fibrillation / therapy
  • Atrial Fibrillation / veterinary
  • Dexmedetomidine / administration & dosage
  • Dexmedetomidine / pharmacology
  • Drug Administration Schedule
  • Electric Countershock / veterinary
  • Female
  • Horse Diseases / therapy
  • Horses
  • Hypnotics and Sedatives / administration & dosage
  • Hypnotics and Sedatives / pharmacology
  • Injections, Intravenous
  • Male

References

This article includes 29 references
  1. McGurrin MKJ, Physick-Sheard PW, Kenney DG. Transvenous electrical cardioversion of equine atrial fibrillation: Patient factors and clinical results in 72 treatment episodes.. J Vet Intern Med 2008;22:609–615.
    pubmed: 18466256
  2. Marr CM, Reef VB, Reimer JM, Sweeney RW, Reid SWJ. An echocardiographic study of atrial fibrillation in horses: Before and after conversion to sinus rhythm.. J Vet Intern Med 1995;9:336–340.
    pubmed: 8531180
  3. Schauvliege S, Van Loon G, De Clercq D, Devisscher L, Deprez P, Gasthuys F. Cardiovascular responses to transvenous electrical cardio-version of atrial fibrillation in anaesthetized horses.. Vet Anaesth Analg 2009;36:341–351.
    pubmed: 19538571
  4. Bellei MH, Kerr C, McGurrin MK, Kenney DG, Physick-Sheard P. Management and complications of anesthesia for transvenous electrical cardioversion of atrial fibrillation in horses: 62 cases (2002–2006). J Am Vet Med Assoc 2007;231:1225–1230.
    pubmed: 17937553
  5. Bettschart-Wolfensberger R, Freeman SL, Bowen IM. Cardio-pulmonary effects and pharmacokinetics of i.v. dexmedetomidine in ponies.. Equine Vet J 2005;37:60–64.
    pubmed: 15651736
  6. Gozalo-Marcilla M, Hopster K, Gasthuys F, Hatz L, Krajewski AE, Schauvliege S. Effects of a constant-rate infusion of dexmedetomidine on the minimal alveolar concentration of sevoflurane in ponies.. Equine Vet J 2013;45:204–208.
    pubmed: 22853551
  7. Marcilla MG, Schauvliege S, Segaert S, Duchateau L, Gasthuys F. Influence of a constant rate infusion of dexmedetomidine on cardio-pulmonary function and recovery quality in isoflurane anaesthetized horses.. Vet Anaesth Analg 2012;39:9–58.
    pubmed: 22151875
  8. Ringer SK, Kalchofner K, Boller J, Fürst A, Bettschart-Wolfensberger R. A clinical comparison of two anaesthetic protocols using lidocaine or medetomidine in horses.. Vet Anaesth Analg 2007;34:257–268.
    pubmed: 17567378
  9. Larenza MP, Kluge K, Conrot A. Cardiovascular effects and recovery quality after S-ketamine or medetomidine infusions supplemental to isoflurane anaesthesia in horses.. Assoc Vet Anaesth Autumn Meeting 2008; Barcelona, Spain.
  10. Lawrence C, Prinzen F, De Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand.. Anesth Analg 1996;82:544–550.
    pubmed: 8623959
  11. Okada H, Kurita T, Mochizuki T, Morita K, Sato S. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts.. Resuscitation 2007;74:538–545.
    pubmed: 17391832
  12. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R. Dexmedetomidine: A novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: A preliminary study.. Anesth Analg 2008;107:1514–1522.
    pubmed: 18931208
  13. Kamibayashi T, Hayashi Y, Mammoto T, Yamatodani A, Sumikawa K, Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.. Anesthesiology 1995;83:992–999.
    pubmed: 7486186
  14. McGurrin MKJ, Physick-Sheard PW, Kenney DG. How to perform transvenous electrical cardioversion in horses with atrial fibrillation.. J Vet Cardiol 2005;7:109–119.
    pubmed: 19083326
  15. Kraus MS, Jesty SA, Gelzer AR. Measurement of plasma cardiac troponin I concentration by use of a point-of-care analyzer in clinically normal horses and horses with experimentally induced cardiac disease.. Am J Vet Res 2010;71:55–59.
    pubmed: 20043781
  16. Hemmings HC, Hopkins PM. Foundations of Anesthesia: Basic Sciences for Clinical Practice.. 2nd ed. St. Louis Missouri: Elsevier Health Sciences; 2006. pp. 511–523.
  17. Power I, Kam P. Principles of Physiology for the Anaesthetist.. 2nd ed. Boca Raton, Florida: CRC Press; 2001. pp. 118–140.
  18. Jesty SA, Kraus M, Gelzer A, Rishniw M, Moïse NS. Effect of trans-venous electrical cardioversion on plasma cardiac troponin I concentrations in horses with atrial fibrillation.. J Vet Intern Med 2009;23:1103–1107.
    pubmed: 19678887
  19. Roekaerts PM, Prinzen FW, De Lange S. Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs.. British J Anaesth 1996;77:427–429.
    pubmed: 8949826
  20. Willigers HM, Prinzen FW, Roekaerts PM, de Lange S, Durieux ME. Dexmedetomidine decreases perioperative myocardial lactate release in dogs.. Anesth Analg 2003;96:657–664.
    pubmed: 12598239
  21. Hofmeister EH, Mackey EB, Trim CM. Effect of butorphanol administration on cardiovascular parameters in isoflurane-anesthetized horses — A retrospective clinical evaluation.. Vet Anaesth Analg 2008;35:38–44.
    pubmed: 17696970
  22. Hopster K, Müller C, Hopster-Iversen C, Stahl J, Rohn K, Kästner S. Effects of dexmedetomidine and xylazine on cardiovascular function during total intravenous anaesthesia with midazolam and ketamine and recovery quality and duration in horses.. Vet Anaesth Analg 2014;41:25–35.
    pubmed: 24127757
  23. Rezende ML, Grimsrud KN, Stanley SD, Steffey EP, Mama KR. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse.. J Vet Pharmacol Ther 2014;38:15–23.
    pubmed: 25066475
  24. Ringer SK, Schwarzwald CC, Portier KG, Ritter A, Bettschart-Wolfensberger R. Effects on cardiopulmonary function and oxygen delivery of doses of romifidine and xylazine followed by constant rate infusions in standing horses.. Vet J 2013;195:228–234.
    pubmed: 22841452
  25. Bettschart-Wolfensberger R, Bettschart RW, Vainio O, Marlin D, Clarke KW. Cardiopulmonary effects of a two hour medetomidine infusion and its antagonism by atipamezole in horses and ponies.. Vet Anaesth Analg 1999;26:8–12.
  26. Bettschart-Wolfensberger R, Clarke KW, Vainio O, Aliabadi F, Demuth D. Pharmacokinetics of medetomidine in ponies and elaboration of a medetomidine infusion regime which provides a constant level of sedation.. Res Vet Sci 1999;67:41–46.
    pubmed: 10425239
  27. Kuusela E, Vainio O, Kaistinen A, Kobylin S, Raekallio M. Sedative, analgesic, and cardiovascular effects of levomedetomidine alone and in combination with dexmedetomidine in dogs.. Am J Vet Res 2001;62:616–621.
    pubmed: 11327474
  28. Gregoretti S, Henderson T, Parks D, Gelman S. Haemodynamic changes and oxygen uptake during crossclamping of the thoracic aorta in dexmedetomidine pretreated dogs.. Can J Anaesth 1992;39:731–741.
    pubmed: 1356647
  29. Rang H. Rang and Dale’s Pharmacology.. Edinburgh, UK: Churchill Livingstone; 2007.